Tim A Kanters

Summary

Affiliation: Erasmus University
Country: The Netherlands

Publications

  1. doi request reprint The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument
    Tim A Kanters
    Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, P O Box 1738, 3000 DR Rotterdam, The Netherlands Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Dr Molewaterplein 60, 3015 GJ, Rotterdam, The Netherlands Electronic address
    Mol Genet Metab 110:281-6. 2013
  2. pmc Systematic review of available evidence on 11 high-priced inpatient orphan drugs
    Tim A Kanters
    Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, PO Box 1738, 3000DR Rotterdam, The Netherlands
    Orphanet J Rare Dis 8:124. 2013
  3. doi request reprint A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers
    Tim A Kanters
    Institute of Health Policy and Management, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Soc Sci Med 76:150-8. 2013
  4. pmc Burden of illness of Pompe disease in patients only receiving supportive care
    Tim A Kanters
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
    J Inherit Metab Dis 34:1045-52. 2011

Detail Information

Publications4

  1. doi request reprint The impact of informal care for patients with Pompe disease: an application of the CarerQol instrument
    Tim A Kanters
    Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, P O Box 1738, 3000 DR Rotterdam, The Netherlands Center for Lysosomal and Metabolic Diseases, Erasmus Medical Center, Dr Molewaterplein 60, 3015 GJ, Rotterdam, The Netherlands Electronic address
    Mol Genet Metab 110:281-6. 2013
    ..Patients with Pompe disease, a rare progressive neuromuscular disorder, receive a considerable amount of informal care. In this study, we examined the impact of providing informal care to patients with Pompe disease...
  2. pmc Systematic review of available evidence on 11 high-priced inpatient orphan drugs
    Tim A Kanters
    Institute for Medical Technology Assessment, Department of Health Policy and Management, Erasmus University Rotterdam, Burgemeester Oudlaan 50, PO Box 1738, 3000DR Rotterdam, The Netherlands
    Orphanet J Rare Dis 8:124. 2013
    ..This study systematically reviews the available evidence on clinical effectiveness, cost-effectiveness and budget impact for orphan drugs...
  3. doi request reprint A new prevention paradox: the trade-off between reducing incentives for risk selection and increasing the incentives for prevention for health insurers
    Tim A Kanters
    Institute of Health Policy and Management, Erasmus University Rotterdam, PO Box 1738, 3000 DR Rotterdam, The Netherlands
    Soc Sci Med 76:150-8. 2013
    ..This highlights a new prevention paradox: improving the level playing field for health insurers will inevitably limit their incentives for promoting the health of their clients...
  4. pmc Burden of illness of Pompe disease in patients only receiving supportive care
    Tim A Kanters
    Department of Health Policy and Management, Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands
    J Inherit Metab Dis 34:1045-52. 2011
    ....